These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8243374)

  • 1. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial.
    Dodson WE
    Epilepsia; 1993; 34 Suppl 7():S18-24. PubMed ID: 8243374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felbamate in the treatment of Lennox-Gastaut syndrome.
    Jensen PK
    Epilepsia; 1994; 35 Suppl 5():S54-7. PubMed ID: 8039473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).
    Felbamate Study Group in Lennox-Gastaut Syndrome
    N Engl J Med; 1993 Jan; 328(1):29-33. PubMed ID: 8347179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate in the treatment of partial-onset seizures.
    Bourgeois BF
    Epilepsia; 1994; 35 Suppl 5():S58-61. PubMed ID: 8039474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felbamate in the treatment of refractory partial-onset seizures.
    Jensen PK
    Epilepsia; 1993; 34 Suppl 7():S25-9. PubMed ID: 8243375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of felbamate in the treatment of intractable pediatric epilepsy.
    Zupanc ML; Roell Werner R; Schwabe MS; O'Connor SE; Marcuccilli CJ; Hecox KE; Chico MS; Eggener KA
    Pediatr Neurol; 2010 Jun; 42(6):396-403. PubMed ID: 20472190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome.
    Siegel H; Kelley K; Stertz B; Reeves-Tyer P; Flamini R; Malow B; Gaillard WD; Ko D; Theodore WH
    Epilepsy Res; 1999 Apr; 34(2-3):91-7. PubMed ID: 10210023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felbamate monotherapy: implications for antiepileptic drug development.
    Theodore WH; Albert P; Stertz B; Malow B; Ko D; White S; Flamini R; Ketter T
    Epilepsia; 1995 Nov; 36(11):1105-10. PubMed ID: 7588454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felbamate: successful development of a new compound for the treatment of epilepsy.
    Schmidt D
    Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term use of felbamate in children with severe refractory epilepsy.
    Cilio MR; Kartashov AI; Vigevano F
    Epilepsy Res; 2001 Nov; 47(1-2):1-7. PubMed ID: 11673015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Felbamate in therapy-resistant epilepsy: an Italian experience. Felbamate Italian Study Group.
    Avanzini G; Canger R; Dalla Bernardina B; Vigevano F
    Epilepsy Res; 1996 Nov; 25(3):249-55. PubMed ID: 8956923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Felbamate monotherapy for partial-onset seizures: an active-control trial.
    Faught E; Sachdeo RC; Remler MP; Chayasirisobhon S; Iragui-Madoz VJ; Ramsay RE; Sutula TP; Kanner A; Harner RN; Kuzniecky R
    Neurology; 1993 Apr; 43(4):688-92. PubMed ID: 8469323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report.
    Marciani MG; Spanedda F; Placidi F; Bassetti MA; Romigi A; Mattia D
    Int J Neurosci; 1998 Sep; 95(3-4):247-53. PubMed ID: 9777442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felbamate: a clinical trial for complex partial seizures.
    Theodore WH; Raubertas RF; Porter RJ; Nice F; Devinsky O; Reeves P; Bromfield E; Ito B; Balish M
    Epilepsia; 1991; 32(3):392-7. PubMed ID: 2044501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
    Palmer KJ; McTavish D
    Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felbamate monotherapy: controlled trial in patients with partial onset seizures.
    Sachdeo R; Kramer LD; Rosenberg A; Sachdeo S
    Ann Neurol; 1992 Sep; 32(3):386-92. PubMed ID: 1416808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felbamate.
    Bourgeois BF
    Semin Pediatr Neurol; 1997 Mar; 4(1):3-8. PubMed ID: 9097361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felbamate in refractory partial epilepsy.
    Canger R; Vignoli A; Bonardi R; Guidolin L
    Epilepsy Res; 1999 Mar; 34(1):43-8. PubMed ID: 10194111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felbamate monotherapy has stimulant-like effects in patients with epilepsy.
    Ketter TA; Malow BA; Flamini R; Ko D; White SR; Post RM; Theodore WH
    Epilepsy Res; 1996 Mar; 23(2):129-37. PubMed ID: 8964274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.